Period of time： 2013年4期
Publisher： Future Medicine
Founded in： 2005
Total resources： 67
ISSN： 1479-6694
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Oncology,volume 8,issue 4
Menu
By Rosenthal Devin T,Merajver Sofia D in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.
Access to resources
Recommend
Future approaches for the therapy of malignant glioma: targeting genes mediating invasion
By Emdad Luni,Dent Paul,Sarkar Devanand,Fisher Paul B in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.By Mathisen Michael S,Ravandi Farhad in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.By Koprivnikar Jamie L,Cheson Bruce D in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.Panitumumab: a summary of clinical development in colorectal cancer and future directions
By Argiles Guillem,Dienstmann Rodrigo,Elez Elena,Tabernero Josep in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.New developments in the treatment of hepatic tumors
By Di Carlo Isidoro,Toro Adriana in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.PKM2: a new player in the &bgr;β-catenin game
By Canal Frédéric,Perret Christine in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.Elevated levels of HSF1 indicate a poor prognosis in breast cancer
By Calderwood Stuart K in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.Bevacizumab and breast cancer: what does the future hold?
By Stevenson Christina E,Nagahashi Masayuki,Ramachandran Subramaniam,Yamada Akimitsu,Bear Harry D,Takabe Kazuaki in (2012)
Future Oncology,volume 8,issue 4 , Vol. 8, Iss. 4, 2012-04 , pp.
Previous
Next